Malignant eccrine spiradenoma

Case report and review of the literature, including 15 Japanese cases

K. Tanese, T. Sato, A. Ishiko

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Malignant eccrine spiradenoma (MES) is an extremely rare cutaneous malignant tumour. An 86-year-old man presented at our hospital with an enlarging tumour on the dorsum of the left hand. An excisional biopsy was taken and histological examination showed a solid island of cells of two distinct types: cells with abundant cytoplasm and oval vesicular nuclei, and small round cells with less cytoplasm and hyperchromatic nuclei with a high frequency of mitosis. We diagnosed this tumour as MES. Although we did not perform further treatment because of the patient's age, there was no sign of recurrence or metastasis in the 2 years of follow-up after excisional biopsy. We reviewed cases of malignant eccrine spiradenoma in the English and Japanese literature and found that 'sarcomatous' or 'squamous' change in histopathology was significantly correlated with a poorer prognosis. It is therefore important for treatment planning to evaluate the entire specimen histologically.

Original languageEnglish
Pages (from-to)51-55
Number of pages5
JournalClinical and Experimental Dermatology
Volume35
Issue number1
DOIs
Publication statusPublished - 2010 Jan

Fingerprint

Cytoplasm
Biopsy
Neoplasms
Mitosis
Hand
Neoplasm Metastasis
Recurrence
Skin
Therapeutics

ASJC Scopus subject areas

  • Dermatology

Cite this

Malignant eccrine spiradenoma : Case report and review of the literature, including 15 Japanese cases. / Tanese, K.; Sato, T.; Ishiko, A.

In: Clinical and Experimental Dermatology, Vol. 35, No. 1, 01.2010, p. 51-55.

Research output: Contribution to journalArticle

@article{4eb6a55047db41f8901276fb0e57be32,
title = "Malignant eccrine spiradenoma: Case report and review of the literature, including 15 Japanese cases",
abstract = "Malignant eccrine spiradenoma (MES) is an extremely rare cutaneous malignant tumour. An 86-year-old man presented at our hospital with an enlarging tumour on the dorsum of the left hand. An excisional biopsy was taken and histological examination showed a solid island of cells of two distinct types: cells with abundant cytoplasm and oval vesicular nuclei, and small round cells with less cytoplasm and hyperchromatic nuclei with a high frequency of mitosis. We diagnosed this tumour as MES. Although we did not perform further treatment because of the patient's age, there was no sign of recurrence or metastasis in the 2 years of follow-up after excisional biopsy. We reviewed cases of malignant eccrine spiradenoma in the English and Japanese literature and found that 'sarcomatous' or 'squamous' change in histopathology was significantly correlated with a poorer prognosis. It is therefore important for treatment planning to evaluate the entire specimen histologically.",
author = "K. Tanese and T. Sato and A. Ishiko",
year = "2010",
month = "1",
doi = "10.1111/j.1365-2230.2008.03072.x",
language = "English",
volume = "35",
pages = "51--55",
journal = "Clinical and Experimental Dermatology",
issn = "0307-6938",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Malignant eccrine spiradenoma

T2 - Case report and review of the literature, including 15 Japanese cases

AU - Tanese, K.

AU - Sato, T.

AU - Ishiko, A.

PY - 2010/1

Y1 - 2010/1

N2 - Malignant eccrine spiradenoma (MES) is an extremely rare cutaneous malignant tumour. An 86-year-old man presented at our hospital with an enlarging tumour on the dorsum of the left hand. An excisional biopsy was taken and histological examination showed a solid island of cells of two distinct types: cells with abundant cytoplasm and oval vesicular nuclei, and small round cells with less cytoplasm and hyperchromatic nuclei with a high frequency of mitosis. We diagnosed this tumour as MES. Although we did not perform further treatment because of the patient's age, there was no sign of recurrence or metastasis in the 2 years of follow-up after excisional biopsy. We reviewed cases of malignant eccrine spiradenoma in the English and Japanese literature and found that 'sarcomatous' or 'squamous' change in histopathology was significantly correlated with a poorer prognosis. It is therefore important for treatment planning to evaluate the entire specimen histologically.

AB - Malignant eccrine spiradenoma (MES) is an extremely rare cutaneous malignant tumour. An 86-year-old man presented at our hospital with an enlarging tumour on the dorsum of the left hand. An excisional biopsy was taken and histological examination showed a solid island of cells of two distinct types: cells with abundant cytoplasm and oval vesicular nuclei, and small round cells with less cytoplasm and hyperchromatic nuclei with a high frequency of mitosis. We diagnosed this tumour as MES. Although we did not perform further treatment because of the patient's age, there was no sign of recurrence or metastasis in the 2 years of follow-up after excisional biopsy. We reviewed cases of malignant eccrine spiradenoma in the English and Japanese literature and found that 'sarcomatous' or 'squamous' change in histopathology was significantly correlated with a poorer prognosis. It is therefore important for treatment planning to evaluate the entire specimen histologically.

UR - http://www.scopus.com/inward/record.url?scp=71949128829&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=71949128829&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2230.2008.03072.x

DO - 10.1111/j.1365-2230.2008.03072.x

M3 - Article

VL - 35

SP - 51

EP - 55

JO - Clinical and Experimental Dermatology

JF - Clinical and Experimental Dermatology

SN - 0307-6938

IS - 1

ER -